Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining Acellular Dermal Grafts With Negative-Pressure Wound Therapy in a Postsurgical Wound: A Case Report.

Advances in skin & wound care·2026
Same author

Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria.

Dermatology and therapy·2026
Same author

Dupilumab subgroup responder analysis: a <i>post hoc</i> analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.

The Journal of dermatological treatment·2026
Same author

Mobile Dermatology Clinics: Opportunities to Expand Medical and Surgical Care Access in Underserved Communities.

Cureus·2026
Same author

Cross-Talk between Neurons and Immune Cells in Pruritus: from Mechanisms To Medicines.

Current allergy and asthma reports·2026
Same author

Sleep Disturbance as a Mediator Between Itch and Quality of Life.

JAMA dermatology·2026

Related Experiment Video

Updated: Jun 7, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.8K

Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report.

Fiona S Gruzmark, Gil Yosipovitch, Hadar A Lev-Tov

    Journal of Drugs in Dermatology : JDD
    |December 2, 2025
    PubMed
    Summary

    Nemolizumab offers a potential new treatment for lichen simplex chronicus, a severe skin condition causing intractable itch. This case study shows nemolizumab significantly improved a patient's quality of life, suggesting its efficacy for this difficult-to-treat disease.

    More Related Videos

    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
    05:39

    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

    Published on: May 16, 2025

    528

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
    06:15

    Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

    Published on: August 9, 2024

    1.8K
    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
    05:39

    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

    Published on: May 16, 2025

    528

    Area of Science:

    • Dermatology
    • Immunology
    • Clinical Case Reports

    Background:

    • Lichen simplex chronicus (LSC) is a chronic skin condition causing intense itching and lichenification.
    • Existing treatments like topical calcineurin inhibitors, gabapentinoids, and dupilumab are often ineffective for LSC.
    • LSC significantly impairs patients' quality of life, leading to anxiety, depression, and sleep disturbances.

    Purpose of the Study:

    • To report a case of successful LSC treatment using nemolizumab.
    • To evaluate the efficacy and safety of nemolizumab in a patient with neuropathic pruritus-associated LSC.

    Main Methods:

    • A case report of a 52-year-old woman with LSC and neuropathic pruritus.
    • Treatment administered was nemolizumab.
    • Patient outcomes and side effects were monitored.

    Main Results:

    • The patient experienced significant improvement in quality of life.
    • No adverse side effects were reported during nemolizumab treatment.
    • Nemolizumab demonstrated potential efficacy in managing LSC symptoms.

    Conclusions:

    • LSC significantly impacts quality of life and necessitates effective management strategies.
    • Current LSC treatments are frequently inadequate.
    • Nemolizumab shows promise as an effective treatment for LSC, warranting further investigation in larger studies.